Covid19_manual_annotation  

PubMed:33576494 JSONTXT 5 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue correct/standard/original word details tao:has_database_id
T10 29-34 Species denotes swine Tax:9823
T22 35-40 Modification denotes glyco MESH:D006031
T20 41-50 Type denotes humanized
T18 51-61 Type denotes polyclonal
T12 62-72 Biological denotes antibodies MESH:D000906
T3 81-91 Species denotes SARS-CoV-2 Tax:2697049
T16 93-105 Type denotes Heterologous
T17 106-116 Type denotes polyclonal
T11 117-127 Biological denotes antibodies MESH:D000906
T39 166-169 Therapy denotes use
T40 166-169 Therapy denotes use
T41 166-169 Therapy denotes use
T33 186-192 Biological denotes plasma
T31 196-217 Biological denotes monoclonal antibodies MESH:D000911
T13 207-217 Biological denotes antibodies
T32 219-223 Biological denotes mAbs MESH:D000911
T6 249-257 Disease denotes COVID-19 MESH:C000657245
T57 289-297 Biological denotes epitopes
T34 308-320 Type denotes heterologous
T14 321-331 Biological denotes antibodies MESH:D000906
T43 340-345 Species denotes human Tax:9606
T42 354-373 Biological denotes xenogeneic antibody MESH:D000910
T54 374-383 Response denotes responses
T51 452-490 Glycan denotes N-glycolyl form of the neuraminic acid https://glytoucan.org/Structures/Glycans/G43724HA
T49 492-498 Glycan denotes Neu5Gc https://glytoucan.org/Structures/Glycans/G43724HA
T52 508-522 Glycan denotes α1,3-galactose https://glytoucan.org/Structures/Glycans/G09546QO
T35 547-561 Disease denotes serum sickness MESH:D012713
T36 565-572 Disease denotes allergy MESH:D006967
T61 583-592 Immunize denotes immunized
T38 593-651 Gene denotes cytidine monophosphate-N-acetylneuraminic acid hydroxylase Gene:396918
T37 685-690 Gene denotes GGTA1 Gene:396733
T62 699-701 Without denotes KO
T30 702-706 Species denotes pigs Tax:9823
T1 716-763 Species denotes Severe acute respiratory syndrome coronavirus 2 Tax:2697049
T2 765-775 Species denotes SARS-CoV-2 Tax:2697049
T58 777-782 Gene denotes spike Gene:43740568
T60 783-806 Biological denotes receptor binding domain
T64 810-817 Produce denotes produce
T24 818-823 Modification denotes glyco MESH:D006031
T21 824-833 Type denotes humanized
T19 834-844 Type denotes polyclonal
T25 845-868 Biological denotes neutralizing antibodies MESH:D057134
T63 869-876 Without denotes lacking
T50 877-883 Glycan denotes Neu5Gc https://glytoucan.org/Structures/Glycans/G43724HA
T53 888-902 Glycan denotes α1,3-galactose https://glytoucan.org/Structures/Glycans/G09546QO
T56 903-911 Biological denotes epitopes
T4 972-982 Species denotes SARS-CoV-2 Tax:2697049
T69 983-993 Type denotes end-titers
T65 994-1011 Index denotes binding dilutions
T66 1012-1033 Value denotes over one to a million
T70 1038-1048 Type denotes end-titers
T67 1049-1071 Index denotes neutralizing dilutions
T68 1075-1083 Ratio denotes 1:10 000
T71 1089-1092 Biological denotes IgG MESH:D007074
T8 1181-1187 Biological denotes XAV-19 MESH:C000716507
T73 1189-1200 Interrupt denotes neutralized
T59 1201-1206 Gene denotes spike Gene:43740568
T26 1207-1238 Gene denotes angiotensin converting enzyme-2 Gene:59272
T72 1239-1250 Interact denotes interaction
T76 1270-1278 Amount denotes <1 μg/mL
T75 1284-1293 NegativeRegulation denotes inhibited
T74 1294-1303 Infection denotes infection
T46 1307-1312 Species denotes human Tax:9606
T5 1322-1332 Species denotes SARS-CoV-2 Tax:2697049
T29 1374-1377 Species denotes pig Tax:9823
T77 1378-1384 Biological denotes GH-pAb Glyco-Humanized Polyclonal Antibody abbreviation
T79 1385-1395 Biological denotes Fc domains
T82 1396-1400 NegativeRegulation denotes fail
T81 1404-1412 Interact denotes interact
T47 1418-1423 Species denotes human Tax:9606
T80 1424-1436 Biological denotes Fc receptors
T86 1446-1454 NegativeRegulation denotes avoiding
T84 1455-1475 Type denotes macrophage-dependent
T85 1476-1487 Severity denotes exacerbated
T83 1488-1500 Disease denotes inflammatory MESH:D007249
T78 1617-1624 Biological denotes GH-pAbs Glyco-Humanized Polyclonal Antibodies abbreviation
T48 1628-1634 Species denotes humans Tax:9606
T9 1666-1672 Biological denotes XAV-19 MESH:C000716507
T7 1681-1689 Disease denotes COVID-19 MESH:C000657245
R1 T10 T12 of_a swine,antibodies
R10 T34 T14 of_a heterologous,antibodies
R11 T11 T39 using antibodies,use
R12 T33 T40 using plasma,use
R13 T31 T41 using monoclonal antibodies,use
R14 T39 T6 for use,COVID-19
R15 T40 T6 for use,COVID-19
R16 T41 T6 for use,COVID-19
R17 T14 T35 cause_of antibodies,serum sickness
R18 T14 T36 cause_of antibodies,allergy
R19 T49 T51 abbreviation Neu5Gc,N-glycolyl form of the neuraminic acid
R2 T22 T12 of_a glyco,antibodies
R20 T42 T54 is_a xenogeneic antibody,responses
R21 T43 T42 of_a human,xenogeneic antibody
R22 T51 T54 against N-glycolyl form of the neuraminic acid,responses
R23 T52 T54 against "α1,3-galactose",responses
R24 T14 T54 cause_of antibodies,responses
R25 T19 T25 of_a polyclonal,neutralizing antibodies
R26 T21 T25 of_a humanized,neutralizing antibodies
R27 T24 T25 of_a glyco,neutralizing antibodies
R28 T2 T1 abbreviation SARS-CoV-2,Severe acute respiratory syndrome coronavirus 2
R29 T58 T60 of_a spike,receptor binding domain
R3 T20 T12 of_a humanized,antibodies
R30 T61 T30 is_a immunized,pigs
R31 T1 T61 against Severe acute respiratory syndrome coronavirus 2,immunized
R32 T30 T62 is_a pigs,KO
R33 T62 T37 is_a KO,GGTA1
R34 T62 T38 is_a KO,cytidine monophosphate-N-acetylneuraminic acid hydroxylase
R35 T62 T64 is_a KO,produce
R36 T64 T25 is_a produce,neutralizing antibodies
R37 T25 T63 is_a neutralizing antibodies,lacking
R38 T63 T56 is_a lacking,epitopes
R39 T50 T56 of_a Neu5Gc,epitopes
R4 T18 T12 of_a polyclonal,antibodies
R40 T53 T56 of_a "α1,3-galactose",epitopes
R41 T69 T65 of_a end-titers,binding dilutions
R42 T70 T67 of_a end-titers,neutralizing dilutions
R43 T68 T67 is_a 1:10 000,neutralizing dilutions
R44 T66 T65 is_a over one to a million,binding dilutions
R45 T59 T72 is_a spike,interaction
R46 T72 T26 is_a interaction,angiotensin converting enzyme-2
R47 T8 T73 is_a XAV-19,neutralized
R48 T73 T72 is_a neutralized,interaction
R49 T5 T74 is_a SARS-CoV-2,infection
R5 T3 T12 against SARS-CoV-2,antibodies
R50 T74 T46 is_a infection,human
R51 T75 T74 is_a inhibited,infection
R52 T8 T75 is_a XAV-19,inhibited
R53 T76 T8 of_a <1 μg/mL,XAV-19
R54 T29 T77 of_a pig,GH-pAb
R55 T47 T80 of_a human,Fc receptors
R56 T77 T79 of_a GH-pAb,Fc domains
R6 T32 T31 abbreviation mAbs,monoclonal antibodies
R60 T85 T83 of_a exacerbated,inflammatory
R61 T84 T83 of_a macrophage-dependent,inflammatory
R62 T79 T82 is_a Fc domains,fail
R63 T82 T81 is_a fail,interact
R64 T86 T83 is_a avoiding,inflammatory
R65 T81 T86 cause_of interact,avoiding
R66 T7 T9 against COVID-19,XAV-19
R7 T16 T11 of_a Heterologous,antibodies
R8 T17 T11 of_a polyclonal,antibodies
R9 T33 T13 - plasma,antibodies